Aeluma CEO Executes Massive 10b5‑1 Sale, Leaves Analysts Puzzled Over Strategic Liquidity Moves
CEO Jonathan Klamkin’s high‑volume 10b5‑1 trades reveal a strategic, risk‑mitigated approach that keeps Aeluma’s $480 M tech stock poised for future growth or a next big event.
3 minutes to read






